Boston Scientific inks $455M deal with global investment firm to work on next-gen heart pump
Cardiovascular Business
Boston Scientific has secured a $455 million deal with a global investment firm to advance its next-generation heart pump technology.
This strategic partnership underscores the company's commitment to revolutionizing cardiovascular care. The investment will enable Boston Scientific to delve into the development of innovative solutions, fostering a symphony of cutting-edge technology and improved patient outcomes.
The deal represents a testament to the company's indelible impact on the medical device landscape, navigating the complex challenges of heart failure with a determined approach. As previously mentioned, this partnership is set to enhance their capabilities and emphasize their position as a game changer in the industry.